3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Hepatitis
1
Colitis
1
Interventions
pembrolizumab
168
Carboplatin
137
Cisplatin
85
Paclitaxel
81
Gemcitabine
79
Pemetrexed
75
Bevacizumab
65
Docetaxel
56
Fluorouracil
50
Oxaliplatin
49
Dexamethasone
47
durvalumab
43
atezolizumab
40
Leucovorin
40
130-nm albumin-bound paclitaxel
40
Capecitabine
38
Cetuximab
36
Rituximab
35
Nivolumab
35
Fulvestrant
35
Cyclophosphamide
34
Injections
31
venetoclax
29
Lenalidomide
29
Prednisone
28
enzalutamide
27
Letrozole
26
pomalidomide
25
Irinotecan
25
daratumumab
22
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
vedolizumab
×
30 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled